Company intelligence / Profile preview

Battery Bio Australia

Brisbane, Queensland, Australia

Ownership: Private
Development stage: Other

Overview

Battery Bio is an Australian biotechnology company pioneering the field of immunometabolism to develop novel therapies for cancer and autoimmune diseases. The company's platform focuses on recharging the immune system by modulating the metabolic pathways that govern T cell function, fitness, and longevity. By targeting metabolic checkpoints, Battery Bio aims to overcome the immunosuppressive environments of tumors and enhance the efficacy of existing immunotherapies. Founded by world-leading experts in immunology and supported by major venture capital, the company is currently advancing a pipeline of small molecule modulators through pre-clinical development.

Therapeutic areas: OncologyImmunology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

BB-TL1A

Beyond the preview

Go deeper on Battery Bio Australia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Battery Bio Australia.

Explore the full profile